Molecular mechanisms of hepatitis B virus-associated liver cancer

Digestive Diseases

Volumn 19, Issue 4, 2001, Pages 279-287

  Rabe, Christian ^a   Cheng, Bin ^a   Caselmann, Wolfgang H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Hepatitis B surface antigens, metabolism; Hepatitis B virus, genetics, metabolism and ultrastructure; Hepatitis B, virology; Hepatocellular carcinoma, virology; Transactivation, genetics; Transactivators, metabolism

Indexed keywords

HEPATITIS B X PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

APOPTOSIS; CELL CLONE; DNA DAMAGE; EXCISION REPAIR; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANTIGENS, VIRAL; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPAIR; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; RISK FACTORS; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 0035731540     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050694     Document Type: Review

References (149)

1. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association
2. Clinical characteristics and outcome of cohort of 101 patients with hepatocellular carcinoma
3. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
4. Distribution of five antigens in hepatocellular carcinoma
5. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma
6. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
7. Hepatitis B virus. The major etiology of hepatocellular carcinoma
8. A case-control study of primary hepatocellular carcinoma in Taiwan
9. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53
10. Experimental WHV infection of woodchucks: An animal model of hepadnavirus-induced liver cancer
11. Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections
12. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans
13. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses
14. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma
15. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks
16. Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma
17. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours
18. Evidence for long-range oncogene activation by hepadnavirus insertion
19. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma
20. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis
21. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas
22. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
23. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma
24. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma
25. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma
26. Hepatitis B virus DNA integration and expression of an erb B-like gene in human hepatocellular carcinoma
27. Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line
28. A t(3;8) chromosomal translocation associated with hepatitis B virus integration involves the carboxypeptidase N locus
29. Inverse polymerase chain reaction for cloning cellular sequences adjacent to integrated hepatitis B virus DNA in hepatocellular carcinomas
30. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas
31. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis
32. Chromosome 17 allele loss in hepatocellular carcinoma but not in synchronous liver adenoma
33. Loss of heterozygosity in liver tumours
34. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma
35. Loss of somatic heterozygosity in hepatocellular carcinoma
36. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
37. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer
38. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas
39. Allelotype study of primary hepatocellular carcinoma
40. Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma
41. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
42. p53 mutations in human hepatocellular carcinomas from Germany
43. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas
44. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma
45. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma
46. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China
47. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
48. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma
49. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis
50. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas
51. Distinctive gene expression profiles associated with hepatitis B virus x protein
52. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas
53. Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators
54. Common evolutionary origin of hepatitis B virus and retroviruses
55. Transcriptional transactivating function of hepatitis B virus
56. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state
57. The HBV X-ORF encodes a transactivator: A potential factor in viral hepatocarcinogenesis
58. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
59. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA
60. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
61. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus
62. Intracellular localization of the hepatitis B virus HBx protein
63. Subcellular localisation of the X protein in HBV infected hepatocytes
64. Transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat by hepatitis B virus X-protein requires de novo protein synthesis
65. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
66. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB
67. The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors
68. Human hepatitis B virus X protein augments the DNA binding of nuclear factor for IL-6 through its basic-leucine zipper domain
69. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis
70. Hepatitis B virus transactivator protein X interacts with the TATA- binding protein
71. Hepatitis B virus pX targets TFIIB in transcription coactivation
72. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation
73. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein
74. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH
75. pX, the Hbv-encoded coactivator, suppresses the phenotypes of Tbp and Tafii250 mutants
76. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5
77. The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators
78. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication
79. The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis
80. The hepatitis B virus X gene product transactivates the HIV-LTR in vivo
81. Hepatitis B virus X gene product acts as a transactivator in vivo
82. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
83. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
84. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
85. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice
86. Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice
87. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice
88. In vivo activity of the hepatitis B virus core promoter: Tissue specificity and temporal regulation
89. Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator
90. The hepatitis B virus pre-S/S(t) transactivator is generated by 3′ truncations within a defined region of the S gene
91. Hepatitis B virus transactivator MHBst: Activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization
92. Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator
93. ER-localization and functional expression of the HBV transactivator MHBst
94. The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors
95. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation
96. Hepatitis B virus surface (S) transactivator with DNA-binding properties
97. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator
98. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum
99. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice
100. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions
101. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis
102. The hepatitis B virus transactivator protein, HBx, interacts with single-stranded DNA (ssDNA). Biochemical characterizations of the HBx-ssDNA interactions
103. Hepatitis B virus X protein inhibits nucleotide excision repair
104. Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes
105. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells
106. Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation
107. Hepatitis B virus X protein interferes with cellular DNA repair
108. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome
109. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit
110. The hepatitis B virus X protein: The quest for a role in viral replication and pathogenesis
111. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex
112. Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway
113. The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein
114. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
115. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
116. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras
117. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
118. Erk-independent partial activation of AP-1 sites by the hepatitis B virus HBx protein
119. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins
120. Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway
121. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings
122. HBx protein of hepatitis B virus activates Jak1-STAT signaling
123. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls
124. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway
125. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway
126. The hepatitis B virus HBx protein inhibits caspase 3 activity
127. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
128. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
129. X-gene product of hepatitis B virus induces apoptosis in liver cells
130. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system
131. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines
132. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts
133. p53-independent apoptotic effects of the hepatitis B virus Hbx protein in vivo and in vitro
134. Pro-apoptotic effect of the hepatitis B virus X gene
135. Effect of hepatitis B virus X protein on the expression of retinoblastoma gene product
136. Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter
137. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade
138. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
139. Association of human papillomavirus types 16 and 18 E6 proteins with p53
140. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
141. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct
142. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
143. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis
144. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx
145. The hepatitis B virus X gene induces p53-mediated programmed cell death
146. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis
147. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: Possible role of HBx in invasion and metastasis
148. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix
149. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner